Containing Or Obtained From Ginkgo (e.g., Ginkgo Biloba, Maidenhair, Etc.) Patents (Class 424/752)
-
Patent number: 7618639Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: October 25, 2007Date of Patent: November 17, 2009Inventor: Jose Angel Olalde Rangel
-
Publication number: 20090274783Abstract: Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herbal extracts of Rhodiola crenulata (root) and Ginkgo biloba (leaf). The composition can be used as a pharmaceutical or nutraceutical to promote mental concentration, and to promote aerobic and anaerobic performance by enhancing strength, endurance, muscle tissue oxygenation, and optimal oxygen consumption.Type: ApplicationFiled: April 17, 2009Publication date: November 5, 2009Applicant: Integrated Chinese Medicine Holdings Ltd.Inventors: Wen Hsien Chou, Vivien Chou
-
Publication number: 20090269426Abstract: This invention relates to combinations of vasoactive substances which are useful in the treatment of sexual dysfunctions associated with poor local blood supply and/or insufficient lubrication. The active compounds are selected from a:—esculoside or visnadine;—forskolin or extracts containing it, or alternatively, purified lipophilic extracts of plants of the genus Ipomea;—esters of ximenynic acid;—optionally, at least one compound selected from a icarin or derivatives or extracts thereof which contain it, amentoflavone, and Gingko biloba dimeric flavones. The combination of these vasoactive substances is incorporated in gels and lotions designed to be applied to the genital organs. These formulations are useful in inducing erection of the male and female sex organs and enhancing orgasm and sexual performance. The formulations are particularly useful in the treatment of female sexual dysfunctions.Type: ApplicationFiled: July 1, 2009Publication date: October 29, 2009Applicant: INDENA S.P.A.Inventor: Ezio BOMBARDELLI
-
Publication number: 20090258095Abstract: The invention relates to the use of Ginkgo biloba for the treatment of mitochondrial diseases of genetic origin and more particularly mitochondrial encephalomyophathies.Type: ApplicationFiled: July 26, 2007Publication date: October 15, 2009Inventors: Arnold Munnich, Francois Clostre, Mehemed Ouzid
-
Patent number: 7601369Abstract: This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The invention describes compositions for a medical foods that are designed to improve cognitive function, induced sleep, a improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as coca. The invention also describes the use of physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.Type: GrantFiled: March 5, 2007Date of Patent: October 13, 2009Assignee: Targeted Medical Pharma Inc.Inventors: William Shell, Elizabeth Charuvastra
-
Patent number: 7597915Abstract: The present invention relates to topical compositions containing: a) Ginkgo biloba terpenes; b) floroglucinols pure or in mixture thereof, extracted from Humulus lupulus, Hypericum sp and Mirtus sp; c) Zanthoxylum bungeanum or Echinacea angustifolia lipophilic extract; for the treatment of atopic dermatitis, skin allergic conditions and acne.Type: GrantFiled: November 8, 2004Date of Patent: October 6, 2009Assignee: Indena S.p.A.Inventor: Ezio Bombardelli
-
Patent number: 7595067Abstract: This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The invention describes compositions for a medical foods that are designed to improve cognitive function, induced sleep, a improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as coca. The invention also describes the use of physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.Type: GrantFiled: March 5, 2007Date of Patent: September 29, 2009Assignee: Targeted Medical Pharma Inc.Inventors: William Shell, Elizabeth Charuvastra
-
Publication number: 20090232916Abstract: Disclosed is a novel food product characterized by a low glucose or glucose free content, a balanced functional fat content, and a proactive agent aimed for the diabetic and diabetic-prone populations. The food product of the invention is a functional food which may be used clinically to lower the lipid level in people suffering from an imbalanced lipid profile and which may progress towards diabetes complications and coronary vascular disorders. In particular embodiments the proactive agent can be any of a naturally occurring lipid, a synthetic or mimetic lipid which is not digestible by humans and interferes with body weight gain/loss, plant extracts and substances derived therefrom, antioxidants, animal-derived substances, minerals and pharmaceuticals, and any mixture thereof.Type: ApplicationFiled: August 9, 2005Publication date: September 17, 2009Inventors: Avidor Shulman, Dori Pelled, Tzafra Cohen
-
Patent number: 7585523Abstract: A method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The compositions for medical foods are designed to improve cognitive function, induced sleep, improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as cocoa. The method uses physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.Type: GrantFiled: August 27, 2002Date of Patent: September 8, 2009Assignee: Targeted Medical PharmaInventors: William Shell, Elizabeth Charuvastra
-
Publication number: 20090220624Abstract: A composition comprising ginkgo biloba or extract or component thereof; apocynin; and a gingerol. The composition may be used to treat diseases such as CF and COPD.Type: ApplicationFiled: March 14, 2007Publication date: September 3, 2009Inventor: Nicholas John Larkins
-
Patent number: 7582315Abstract: This invention describes a method and composition to enhance the synthesis and release of the neurotransmitters by the oral administration of neurotransmitter precursors, along with natural plant substances that stimulate uptake of the neurotransmitters precursors, while adding natural plant substances that activate adenylate cyclase in order to avoid attenuation and prevent pharmacologic tolerance. The invention describes compositions for a medical foods that are designed to improve cognitive function, induced sleep, a improve Parasympathetic function, improve autonomic balance, increase nitric oxide production, reduce blood pressure, increase blood flow, and treat virus infections. The compositions include amino acids such as choline, herbs such ginkgo biloba, and other foods such as coca. The invention also describes the use of physiologic tests such as 24 hour ECG monitoring to create the appropriate combinations and assess the useful proportions.Type: GrantFiled: March 5, 2007Date of Patent: September 1, 2009Assignee: Targeted Medical Pharma, Inc.Inventors: William Shell, Elizabeth Charuvastra
-
Patent number: 7569236Abstract: The subject of the present invention is a new stable herbal drug formulation in the form of sustained-release microgranules containing Gingko Biloba extract as well as the process for preparing it.Type: GrantFiled: October 11, 2004Date of Patent: August 4, 2009Assignee: EthypharmInventors: Dominique Marechal, Wei-hong Yang, Yu-zhang Hu
-
Patent number: 7560447Abstract: The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.Type: GrantFiled: April 27, 2007Date of Patent: July 14, 2009Assignee: N.V. NutriciaInventors: Amanda Johanne Kiliaan, Robert Johan Joseph Hageman
-
Publication number: 20090175968Abstract: Dietary compositions are disclosed herein. For example, dietary compositions containing a combination of a phosphatidylserine, DHA, EPA, antioxidants, and Ginkgo Biloba are provided.Type: ApplicationFiled: January 2, 2009Publication date: July 9, 2009Inventors: Jeremy Ivie, Jennifer Kelsey, Alexander B. Rabovsky
-
Patent number: 7556828Abstract: A pharmaceutical composition with higher curative effect on benign prostate hyperplasia and emiction disorders. It uses plants such as ginseng and ginkgo as well as cassia twig, cinnamon and liquorices as raw materials in both food and medicine. These raw materials are decocted or extracted separately in ethanol solution or water, then concentrated and dried to make the said pharmaceutical composition. Because this pharmaceutical composition is not toxic and has no side effect, it can be prepared as a medicament and health food to treat and improve benign prostate hyperplasia and emiction disorders caused by benign prostate hyperplasia.Type: GrantFiled: April 4, 2003Date of Patent: July 7, 2009Inventors: Zuguang Zhang, Yufen Wang
-
Publication number: 20090169652Abstract: Personal care compositions comprising an active component, use of such compositions, and methods of marketing such compositions. The personal care compositions can be applied topically, ingested orally, injected, or used as part of a regimen.Type: ApplicationFiled: November 20, 2008Publication date: July 2, 2009Inventor: Rosemarie Osborne
-
Patent number: 7553503Abstract: A Phytoceutical composition for the prevention and treatment of Parkinson's disease is provided. A specific combination of extracts of plants and nutraceuticals is based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combination has synergistic effects, with minimal side effects.Type: GrantFiled: November 16, 2006Date of Patent: June 30, 2009Inventor: Jose Angel Olalde Rangel
-
Publication number: 20090123575Abstract: Methods for treating amyloid disease in a patient wherein the method comprises administration of a therapeutically effective amount of a composition comprising Uncaria tomentosa extract, Gingko Biloba, Green Tea Extract, Grape Seed Extract and/or Curcumin.Type: ApplicationFiled: October 10, 2008Publication date: May 14, 2009Inventors: Thomas Lake, Alan Snow
-
Publication number: 20090123571Abstract: A method of treating Alzheimer's disease, Parkinson's disease, sexual dysfunction or erectile dysfunction in a man by administration of a 5alpha reductase inhibitor together with a testosterone supplement is described. The method is also concerned with the use of the 5alpha reductase inhibiting compound and the testosterone supplement together with another agent useful for treating erectile dysfunction, including PDE V inhibitors; AGE (advanced glycation end-product) breakers; alpha 1 blockers; alpha 1A antagonists; alpha 2 antagonists; dopamine agonists; dopamine D4 agonists; melanocortin agonists; oxytocin agonists; prostaglandin; radical scavengers; rotamase inhibitors; aviptadil; nitroglycerine; and GPCR agonists for treating male sexual dysfunction or erectile dysfunction.Type: ApplicationFiled: March 21, 2006Publication date: May 14, 2009Inventor: Alan Meehan
-
Publication number: 20090123564Abstract: Novel compositions for hair loss prevention and/or hair growth promotion comprising at least active agent preferably derived from natural source such as from the plant Vernonia sp., either alone or in combination with other active agent(s) and optionally one or more excipient(s) are provided. The process for the extraction of hair growth promoting agent and preparation of compositions comprising such active agent are also described. The novel composition is preferably in the form of an oral or topical preparation such as tablet, capsule, liquid solution or suspension, cream, gel, lotion or spray and is useful against hair disease(s)/disorder(s) and/or other associated disorders particularly in the management of testosterone induced androgenic alopecia.Type: ApplicationFiled: March 19, 2007Publication date: May 14, 2009Inventors: Rajesh Jain, Kour Chand Jindal, Aniruddha Datta
-
Publication number: 20090110745Abstract: The present invention provides methods for improving cognitive function, improving mood, and decreasing aggression in a normal adult subject, and in a subject having symptoms characteristic of a neurological disorder, by administration of a nutriceutical formulation of the invention to the subject. The invention additionally features methods of treating neurological disorders, depression, and aggression using nutriceutical formulations. Nutriceutical compositions and formulations for use in the methods of the invention, and kits containing nutriceutical compositions and formulations, are also provided.Type: ApplicationFiled: April 4, 2008Publication date: April 30, 2009Applicant: UNIVERSITY OF MASSACHUSETTS LOWELLInventors: Thomas B. Shea, Amy Y. Chan-Daniels
-
Publication number: 20090098096Abstract: The invention relates to medicine, in particular to pharmacology, and is embodied in the form of an agent for limiting neuro-mediator, neuro-endocrine and metabolic disturbances generating the disorders of a central nervous system and functional somatic disorders. The inventive agent is based on a DSIP (delta sleep inducing peptide) or a derivative chemically related thereto and can be used for correcting and preventing functional shifts in a central nervous system and concomitant somatic disorders caused by unfavourable and extreme environmental factors and different pathological conditions of an organism or during the ageing thereof.Type: ApplicationFiled: August 23, 2006Publication date: April 16, 2009Inventors: Inesa Ivanovna Mikhaleva, Vadim Tikhonovich Ivanov, Igor Arkadjevich Prudchenko, Boris Olegovich Voitenkov
-
Publication number: 20090068167Abstract: The present invention relates to compositions and methods for promoting healing of cutaneous, mucosal and/or mucocutaneous lesions associated with the presence of a mycoplasma and one or more non-mycoplasma microorganisms.Type: ApplicationFiled: February 19, 2008Publication date: March 12, 2009Inventor: Maria de Lourdes HIGUCHI
-
Publication number: 20090068296Abstract: This invention relates to products and methods for improving sensory qualities of meat obtained from livestock. In particular, this invention relates to products and methods for reducing off-odors and off-tastes in meat from uncastrated male pigs (boar taint) or from other livestock fed on pasture. According to the invention, this is obtained by administering a product that contains an inducer of the constitutive androstane receptor (CAR). These include plant products derived from Artemisia spp, Citrus spp., Gingko biloba, Tagetes lucida, as well as vitamin E (alpha tocopherol). The CAR-inducer products of the invention may be used to reduce boar taint and thereby eliminate the need for castration of male pigs.Type: ApplicationFiled: February 22, 2007Publication date: March 12, 2009Inventor: Douglas L. Greger
-
Patent number: 7498048Abstract: A Phytoceutical composition for the prevention and treatment of renal disorders is provided. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have effects, with minimal side effects.Type: GrantFiled: November 16, 2006Date of Patent: March 3, 2009Inventor: Jose Angel Olalde Rangel
-
Publication number: 20090022825Abstract: The invention provides methods of diagnosing mild cognitive impairment (MCI) in a patient and methods of predicting cognitive decline in patients who have MCI. The invention also provides methods for predicting if a patient who has MCI will develop Alzheimer's Disease (AD).Type: ApplicationFiled: May 2, 2008Publication date: January 22, 2009Inventors: Daniel Kerkman, John F. DeBernardis, Raymond Zinkowski, Harald Juergen Hampel
-
Publication number: 20090011048Abstract: A dietary supplement for removing or preventing the bio-accumulation of heavy metals in the body includes one or more chelators, precursors therefore, with at least one chelator capable of crossing the blood brain barrier to promote capture of a heavy metal ion from a site in the central nervous system, and a vascular system promoter for assisting in distributing the chelators within the body. The chelator then crosses back through the blood brain barrier with the entrained heavy metal ion. Preferably, one or more secondary chelators promotes binding any of the heavy metal released from the primary chelator and hold it for removal via an excretion pathway. In one embodiment, the supplement includes a cilantro extract to assist the body's' natural defense systems in removing mercury from the human body.Type: ApplicationFiled: September 18, 2008Publication date: January 8, 2009Inventors: Henry D. COLEMAN, R. Neil SUDOL, William J. SAPONE
-
Publication number: 20080317869Abstract: Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions.Type: ApplicationFiled: June 16, 2008Publication date: December 25, 2008Inventor: Jef Gazley
-
Publication number: 20080292733Abstract: The present invention is directed to antioxidative and antiproliferative agents containing North American ginseng (proprietary extract HT1001) alone or in combination with Ginkgo biloba (GB), Saint John's Wort (SJW), ginkgolides, flavonoids, ginsenosides, hypericin, and/or hyperforin. The antioxidative and antiproliferative agents according to the present invention show significant inhibition of Fe2+-catalyzed lipid peroxidation and Fe2+ chelation activity, the ability to scavenge hydroxyl free radicals, the ability to reduce neuroblastoma cell numbers, and/or the ability to promote neurite outgrowth. These effects are consistent with the behavior of Fe2+ chelators and the variance in both type and magnitude of effects exerted by the chemical components suggests a synergistic mechanism of action.Type: ApplicationFiled: October 16, 2006Publication date: November 27, 2008Inventors: Sharla K. Sutherland, Jacqueline J. Shan
-
Publication number: 20080286391Abstract: The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, which is obtainable by the method according to the present invention, as well as to its use.Type: ApplicationFiled: July 9, 2008Publication date: November 20, 2008Applicant: Bioplanta Arzneimittel GmbHInventors: Clemens Erdelmeier, Hermann Hauer, Egon Koch, Friedrich Lang
-
Publication number: 20080279900Abstract: A gel, for cosmetic use, composed of a mixture of a polymer which forms a gel, a surfactant, and propionyl L-carnitine glycinate hydrochloride, useful for treating disturbances of the skin such as cellulite and wrinkles is described.Type: ApplicationFiled: November 9, 2007Publication date: November 13, 2008Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPAInventors: Antonio Longo, Mose Santaniello, Paola Risi
-
Publication number: 20080267939Abstract: A Phyto-nutraceutical composition for the prevention and treatment of hypertensive disorders is provided. A specific combination of extracts of plants and nutraceuticals is provided, based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combinations have synergistic effects, with minimal side effect.Type: ApplicationFiled: September 29, 2006Publication date: October 30, 2008Inventor: JOSE ANGEL OLALDE RANGEL
-
Publication number: 20080254126Abstract: To supply the ginkgo biloba extract which contains no ginkgolic acid but the active ingredient of existing ginkgo biloba extract and which achieves significant effects in activation of the brain cells. The composition comprises nanoparticle ginkgo biloba extract as the active ingredient, which has the effect of brain function activation. The ginkgo biloba extract is free of ginkgolic acid and is made with the breakdown method, the combination of dry and wet process, crushing ginkgo biloba extract powder. The nanoparticle is 100 nm and below. The above composition has the form from the group consisting of condiments, food additives, food materials, food and drink, health food and drink, drugs, quasi drugs and feeding stuffs. The above health food and drink is for patients with abnormality in cerebral blood flow and metabolism and with the effect of brain function activation prevents or improves the symptom. The above drugs and quasi drugs are intended for human or animal use.Type: ApplicationFiled: March 20, 2007Publication date: October 16, 2008Inventor: Shinji Shimada
-
Publication number: 20080254155Abstract: The use of ginkgo biloba extract in preparation of a composition for lowering cholesterol is provided. Furthermore, the use of ginkgo biloba extract in preparation of a composition for modulating the gene expressions of key enzymes associated with cholesterol metabolism in vivo is provided. Also the use of a set of changes in gene expressions at the level of genes and proteins.Type: ApplicationFiled: October 23, 2006Publication date: October 16, 2008Applicants: SHANGHAI BIOCHIP CO., LTD, SHANGHAI XINGLING SCI. & TECH. PHARMACEUTICAL CO., LTD.,Inventors: Xiaomei Gu, Delong Xie, Qinghua Zhang, Qi Gao, Gang Liu, Guoan Zhang, Huasheng Xiao, Hongjun Yang, Guoping Zhao, Lu Zhang
-
Publication number: 20080226757Abstract: The invention is directed to the use of Ginkgo complexed with phosphatidylserine for the manufacture of a medicament or a dietary supplement for the enhancement of cognitive function and mental fatigue, i.e. to improve the factors related therewith such as to improve the speed of memory and memory quality, to increase accuracy and attention in activities in normal, healthy subjects, to prevent deterioration of the speed and quality of memory in people with decreased cognitive functions and to counteract cognitive fatigue, having also an influence on the mood, particularly in healthy children, young adults, middle-aged and/or old people. It is further provided the use of the Ginkgo phosphatidylserine complex for the treatment and prevention of a disease related with a decrease of the cognitive function and mental fatigue such as Dementia, e.g. Alzheimer's Disease.Type: ApplicationFiled: January 26, 2005Publication date: September 18, 2008Inventors: Paolo Morazzoni, Orlando Petrini, Andrew Scholey, David Kennedy
-
Publication number: 20080213406Abstract: Disclosed are compositions for promoting general health and well-being, comprising an extract of a botanical raw material, wherein said extract inhibits the carboxyl demethylating activity of a protein phosphatase, and methods of making and using same.Type: ApplicationFiled: August 3, 2007Publication date: September 4, 2008Applicant: SIGNUM BIOSCIENCES, INC.Inventors: Jeffry Stock, Maxwell Stock, Haoming Gu, Gregory Stock, Zhu Li, Peter Wolanin
-
Publication number: 20080193572Abstract: Novel extracts from the leaves of Ginkgo biloba, comprising 20 to 30%, by weight, of flavone glycosides; 2.5 to 4.5%, by weight in the aggregate, of ginkgolides A, B, C and J; 2.0 to 4.0%, by weight, of bilobalides; less than 10 ppm of alkyl phenol compounds; and more than 10%, by weight, of oligomeric proanthocyanidins, useful for pharmaceutical, dietary supplements and/or functional food/nutraceutical compositions, and a novel process for obtaining such extracts.Type: ApplicationFiled: July 1, 2006Publication date: August 14, 2008Inventors: Christophe Carite, Santiago Rull Prous, Smail Alaoui Ismaili, Pedro Forner, Christine Gartner, Sybille Buchwald-Werner
-
Publication number: 20080181975Abstract: This invention provides a vasoprotective agent containing a plant or its extract as an effective ingredient. The plant is selected from the group consisting of rosemary, sage, geranium herb, adlai, field horsetail, bitter orange peel, fucus, burdock, dokudami, Japan pepper, Ophiopogon tuber, ginkgo, natsume and dishcloth gourd.Type: ApplicationFiled: January 31, 2007Publication date: July 31, 2008Applicant: Kao CorporationInventors: Naonobu Yoshizuka, Yuko Fukuda, Yasuko Amano, Minoru Takizawa, Hajime Soga, Shinobu Mori, Akira Hachiya
-
Publication number: 20080171085Abstract: A novel biphasic pharmaceutial or nutraceutical composition delivers both an immediate and a sustained dose of a pharmaceutical or nutraceutical agent in the same unit dose. An oral unit dose of melatonin includes melatonin in a sustained-release matrix contained in a solid phase, such as a tablet of capsule, and also includes melatonin in a film dispersed on the surface of the solid phase. Approximately 80 to 90 weight percent of the total amount of melatonin of each unit is contained in the sustained-release matrix and the remainder in the film. The novel composition permits a mammal, including a human being, to both rapidly fall asleep and remain asleep for a desired period of time by releasing an immediate-release dose and a sustained-release dose of melatonin.Type: ApplicationFiled: January 11, 2007Publication date: July 17, 2008Inventors: Dahlia Elnekave, Gopi Mohan Sundaram, Michael Todd Yatcilla
-
Publication number: 20080166383Abstract: The present invention provides an antiallergic latex or PVC product, which includes one or more natural antiallergic medicines selected from baicalin, matrine, liquorice saponin, tea polyphenol, arctigenin, oleanolic acid, tetrandrine, sodium ferulate, total alkaloid of asiatic moonseed rhizome, extraction of cortex dictamni radics, ginkgo bilobal A, total glycoside of Rhizoma Anemones flaccidae, extraction of engelhardtia chryolepis, magnolin, osthole, catechin. The latex or PVC products of the present invention are generally in the forms of glove or condom. The present invention solves the problem of hypersensitivity to condom or glove in prior arts by adding the natural antiallergic medicine into the matrix of latex or PVC.Type: ApplicationFiled: December 9, 2005Publication date: July 10, 2008Inventors: Zhengming Zhou, Yan Jiang
-
Patent number: 7381430Abstract: The present invention provides a pharmaceutics of traditional Chinese medicine and preparation method thereof, said pharmaceutics is prepared from Geranium, Root of Membranous Milkvetch, Herba Solani Nigri, Honeysuckle Flower, Flower of Common Bombax, Fruit of Belleric Terminalia, Herba Hedyotis Diffusae, Pomegranate Rind, Radix Oryzae, Fructus Trapae. The pharmaceutics of the present invention can clear away heat and toxic materials, activate blood circulation and supplementing qi, raise bacteria count of CD4 lymphocyte of infected person of AIDS and subject of AIDS (CD4 lymphocyte 100-400 unit/mm³), and ameliorate hypodynamia, alopecia, anorexia, diarrhea, and status of activity function.Type: GrantFiled: May 24, 2004Date of Patent: June 3, 2008Assignee: Beijing Qijieyuan Pharmaceutical Technology Development Co., Ltd.Inventors: Zuqin Lai, Xuhuai Huang
-
Publication number: 20080118583Abstract: A Phytoceutical composition for the prevention and treatment of Parkinson's disease is provided. A specific combination of extracts of plants and nutraceuticals is based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combination has synergistic effects, with minimal side effects.Type: ApplicationFiled: November 16, 2006Publication date: May 22, 2008Inventor: JOSE ANGEL OLALDE RANGEL
-
Publication number: 20080118553Abstract: The subject invention provides a composition comprising a mixture of polypeptides in the form of a tannate salt wherein each polypeptide is a copolymer of the amino acids L-glutamic acid, L-alanine, L-tyrosine and L-Lysine, methods of preparation and uses thereof.Type: ApplicationFiled: June 12, 2007Publication date: May 22, 2008Inventors: Anton Frenkel, Arthur A. Komlosh
-
Patent number: 7371415Abstract: The invention provides methods and compositions for maintaining a state of wellness in a human by providing a dietary supplement comprising L-arginine, alone or in combination with either ginseng or ginkgo biloba or the combination of all three. The composition may be provided in a carrier base such as an edible food. Optionally additional nutritional supplements may be combined. The invention provides a unique blend of components that, in combination, synergistically bestow sexual wellness upon a human when taken regularly as a dietary supplement.Type: GrantFiled: April 8, 2002Date of Patent: May 13, 2008Assignee: The Daily Wellness CompanyInventors: Hank C. K. Wuh, Aileen S. Trant
-
Patent number: 7341750Abstract: Disclosed herein are a novel compound isolated from Ginkgo biloba and a method for isolating the novel compound from Ginkgo biloba. The method comprises: (1) extracting Ginkgo biloba with alcohol to obtain a crude extract; (2) subjecting the Ginkgo biloba crude extract to solvent fractionation using an organic solvent; (3) fractionating the solvent fractions by Sephadex column chromatography; and (4) fractionating the Sephadex fractions by silica gel column chromatography.Type: GrantFiled: November 8, 2006Date of Patent: March 11, 2008Assignee: Candleflower Co., Ltd.Inventors: Hyun-Jung Lee, Hak-Ju Lee, Kang-Hoon Je, Jeong Kon Seo, Seung Jin Lee, Sun Li Bang
-
Patent number: 7338672Abstract: Estrogen-deficiency related cognitive dysfunction may be improved by administering a composition comprising an herbal composition to a woman. In a preferred embodiment the herbal composition comprises whole plant extract of Leucojum aestivum.Type: GrantFiled: December 22, 2005Date of Patent: March 4, 2008Assignee: Herbaceuticals, Inc.Inventor: Tricia Grose
-
Publication number: 20080026082Abstract: A Phytoceutical composition for the prevention and treatment of erectile dysfunction is provided. A specific combination of extracts of plants and nutraceuticals is based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combination has synergistic effects, with minimal side effects.Type: ApplicationFiled: July 28, 2006Publication date: January 31, 2008Inventor: Jose Angel Olalde Rangel
-
Patent number: 7323198Abstract: The invention relates to structured water and its antioxidant activity. In addition, the present invention relates to antioxidants incorporated within the cluster structure of either electropositive (S water) or electronegative (I water). The structured water, having the antioxidant within its cluster structure, has a stabilizing effect on the antioxidant. In addition, the antioxidant activity inherent to structured water is enhanced by the presence of the antioxidant within its cluster structure. The present invention also includes methods of removing or reducing free radicals on the skin and thereby preventing the signs of skin aging and the risks of cancer associated with the presence of free radicals in the skin.Type: GrantFiled: July 27, 2005Date of Patent: January 29, 2008Assignee: Color Access, Inc.Inventors: Vasile Ionita-Manzatu, Mirela Ionita-Manzatu, Gheorghe Cicoa, Andrew J. Bevacqua
-
Publication number: 20080020071Abstract: A composition protects against, minimizes the effects of, and hastens recovery from the typical symptoms associated with an alcohol induced hangover. The composition includes superoxide dismutase (SOD), and prickly pear cactus (OFI). In addition, sesamin and alpha-lipoic acid work with the SOD and OFI for enhanced antioxidant and therapeutic effects. Other ingredients can be added to the composition for additional treatment of symptoms.Type: ApplicationFiled: July 24, 2006Publication date: January 24, 2008Inventor: Victor H. Diaz
-
Publication number: 20080014293Abstract: Disclosed herein are a novel compound isolated from Ginkgo biloba and a method for isolating the novel compound from Ginkgo biloba. The method comprises: (1) extracting Ginkgo biloba with alcohol to obtain a crude extract; (2) subjecting the Ginkgo biloba crude extract to solvent fractionation using an organic solvent; (3) fractionating the solvent fractions by Sephadex column chromatography; and (4) fractionating the Sephadex fractions by silica gel column chromatography.Type: ApplicationFiled: November 8, 2006Publication date: January 17, 2008Inventors: Hyun-Jung Lee, Hak-Ju Lee, Kang-Hoon Je, Jeong Kon Seo, Seung Jin Lee, Sun Li Bang